NMC Health reiterates guidance after rating downgraded

NMC Health has reiterated its guidance for 2018 and 2019, saying management remains comfortable with anticipated year-on-year EBITDA growth of 36% in 2018 and 18-20% in 2019. UAE-based NMC also repeated its expectations for top line growth of 24% in 2018 and 22-24% in 2019. However, the company revised its KPIs for management long-term incentive…

You must be a HM or HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe to HM » Subscribe to HMI »